Fund databasePrivate Equity

MCF Access Feeder

Mata Capital IM · FR001400O770

Private Equity France Buyout Growth Equity Primaries / Target Funds

NAV
Fund currencyEUR
Income treatment
Performance
Ongoing costs3.60% p.a.
Min. investmentEUR 100,000
Redemptionquarterly
Risk (SRI)6 / 7

01Performance

We do not yet have a NAV series for this fund. Semi-liquid funds often publish their unit prices only monthly or quarterly — and not always publicly.

Provider figures

These come from the factsheet, the PRIIPs KID or the monthly report. They may relate to a different reference date, a different share class or a longer period than the series above — the series starts with the first documented unit price, not necessarily with the launch. That is why the values sometimes differ.

Target return per the provider: 15 % IRR (target return)

Provider figure or KID scenario — not a forecast by semiliquid.info. Target returns are not guaranteed.

02Strategy & portfolio

What the fund does and how the portfolio is put together.

Launch year2024
Fund size
CurrencyEUR
Income treatment
SFDR
Recommended holding
Liquidity buffer
Leverage limit

Risk indicator 6 of 7 from the key information document (1 = low, 7 = high); it captures liquidity risks only to a limited extent.

Portfolio breakdown

Broken down using semiliquid’s common taxonomy — provider labels are mapped onto shared categories so that funds can be compared. Only published figures are used; nothing is estimated.

Sector breakdown

Approximation (qualitative)% of NAVas at 21 Aug 2026

Healthcare & life sciencesThe provider reports the portfolio as a single position — no finer breakdown is published.
Source: Fondsdokumente des Anbieters (KID/Prospekt/Präsentation), qualitative Angabe ohne Prozentwerte — Belegzitate in den Spalten 'Text: Sektorfokus' und 'Text: Regionenfokus'

Geographic breakdown

Approximation (qualitative)% of NAVas at 21 Aug 2026

Global, not broken downThe provider reports the portfolio as a single position — no finer breakdown is published.
Source: Fondsdokumente des Anbieters (KID/Prospekt/Präsentation), qualitative Angabe ohne Prozentwerte — Belegzitate in den Spalten 'Text: Sektorfokus' und 'Text: Regionenfokus'

Strategy

Buyout Growth Equity Primaries / Target Funds

Feeder into the evergreen fund of funds 'Med Access' run by ARCHIMED (internal fund of funds); growth/buyout

03Costs

The basis is the PRIIPs KID of the share class we track — which makes it comparable across providers.

Management feenot documented
Total ongoing costs3.60%
Entry charge max.5.00%
Redemption feenot documented
Performance fee0.00%
Hurdle ratenot documented
High-water marknot documented

In context: ongoing costs

This fund
3.60%
Median Private Equity
2.53%

Median across 31 funds in this asset class in our database, based on the PRIIPs KID. No statement about quality — cost structures differ depending on the strategy and on target-fund layers.

How the performance fee works

No mechanism at feeder level (no performance fee of its own). The mechanism of the target fund Med Access (ARCHIMED) – rate, hurdle, catch-up, HWM, crystallisation, whole-fund vs. deal-by-deal – could not be established: n/a

Costs per the key information document

3.6 % p.a. ongoing costs including indirect costs (derived from the DIC/KID). A breakdown into the feeder's administrative and operating costs, the target fund's costs, transaction costs and the cost impact of the performance fee, as well as the annual total cost impact (reduction in yield), are not disclosed.

04Subscription & entry

How you get into the fund, and on what terms.

Subscriptionnot documented
Minimum investmentEUR 100,000
Entry chargeup to 5.00%
Rec. holding periodnot documented

05Redemption & liquidity

Semi-liquid means redemption only on fixed dates, with notice periods and upper limits. This is how it works for this fund — in the order the redemption process runs.

Units can be redeemed quarterly; on each date the fund redeems at most 5 % of fund assets; for the first 36 months after subscription no redemption is possible.

1 · Lock-up36 months from subscription
2 · Notice periodunknown
3 · Redemption datequarterly
4 · Gatemax. 5 % per date
5 · Payoutnot documented

The gate caps redemptions at 5 % of fund assets per date. If more investors want out at the same time, orders are scaled back pro rata or deferred to the next date.

Redemption per the document

quarterly, first possible after 3 years

Gate per the document

5 % of net assets

Notice period

not documented

Lock-up

3-year lock-up period; thereafter a 5 % penalty fee on redemption within 3 years of release; recommended holding period 8 years

06Fund details & verification

Who stands behind the fund, who it is authorised for — and what the figures rest on.

AIFM / management company

Mata Capital IM

Launch date

July 2024

Eligible investors

professional and semi-professional investors

Distribution authorisation

France (not within Assurance-Vie)

Fee layers / double charging

UNAMBIGUOUS TWO-TIER STRUCTURE (FEEDER-MASTER). MCF Access Feeder is a pure FEEDER FUND run by Mata Capital IM into the target fund 'Med Access' managed by ARCHIMED (healthcare/life sciences private equity). Investors therefore bear BOTH levels: the feeder's management fee (Mata Capital IM) AND the management fee and carried interest of the target fund (ARCHIMED). The figure disclosed of 3.6 % p.a. is declared as 'ongoing costs including indirect costs' and should capture both levels; the performance participation arising at target-fund level is NOT included in it (feeder level: 0 %)

All figures come from our analysis of provider documents (product data as at 19 Aug 2026, distribution data as at 12 Aug 2026) and have not been conclusively verified.

Similar funds

Same asset class, sorted by overlap of sub-strategy — no recommendation, no ranking.

Important information. semiliquid.info does not provide investment advice and makes no recommendation to buy, sell or hold fund units — no ranking, no offer, no invitation to subscribe. Only the prospectus and the key information document (PRIIPs KID) of the respective fund are authoritative. We give no warranty for the accuracy, completeness or currency of the information. Semi-liquid funds invest in illiquid assets: redemptions are possible only to a limited extent and can be capped, deferred or suspended; there is a risk of total loss. Past performance is not a reliable indicator of future results. Read the prospectus and the key information document before making an investment decision and seek professional advice where appropriate.